Analysis
In-depth analysis of pharmaceutical markets, supply chains, technology and regulation
#CDMO ×
Analysis
Aug 30, 2026•1 min read
High Won Exchange Rate Affects Pharma & Bio Companies Differently
While a weak won usually boosts exporters, pharma and biotech firms see mixed effects as foreign revenue growth is offset by rising foreign‑currency costs for raw materials, debt and liabilities.
Analysis
Aug 26, 2026•1 min read
Kimball Electronics Pursues M&A to Expand Life‑Science CDMO Footprint in Europe and India
Kimball Electronics announced plans to grow its life‑science contract manufacturing capabilities through acquisitions in Europe and India.
1